205 related articles for article (PubMed ID: 11126446)
1. The neurosurgical management of prolactinomas.
Gökalp HZ; Deda H; Attar A; Uğur HC; Arasil E; Egemen N
J Neurosurg Sci; 2000 Sep; 44(3):128-32. PubMed ID: 11126446
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery.
Amar AP; Couldwell WT; Chen JC; Weiss MH
J Neurosurg; 2002 Aug; 97(2):307-14. PubMed ID: 12186458
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery.
Han YL; Chen DM; Zhang C; Pan M; Yang XP; Wu YG
Medicine (Baltimore); 2018 Nov; 97(45):e13198. PubMed ID: 30407358
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
5. Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists?
Turner HE; Adams CB; Wass JA
Eur J Endocrinol; 1999 Jan; 140(1):43-7. PubMed ID: 10037250
[TBL] [Abstract][Full Text] [Related]
6. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
Soule SG; Farhi J; Conway GS; Jacobs HS; Powell M
Clin Endocrinol (Oxf); 1996 Jun; 44(6):711-6. PubMed ID: 8759184
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
Primeau V; Raftopoulos C; Maiter D
Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
[TBL] [Abstract][Full Text] [Related]
8. The use of surgery for the treatment of prolactinomas.
van't Verlaat JW
Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():34-7. PubMed ID: 8103958
[TBL] [Abstract][Full Text] [Related]
9. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M
Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Hamilton DK; Vance ML; Boulos PT; Laws ER
Pituitary; 2005; 8(1):53-60. PubMed ID: 16411069
[TBL] [Abstract][Full Text] [Related]
11. Prolactinomas in children under 14. Clinical presentation and long-term follow-up.
Liu Y; Yao Y; Xing B; Lian W; Deng K; Feng M; Wang R
Childs Nerv Syst; 2015 Jun; 31(6):909-16. PubMed ID: 25771923
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
13. Medically treated prolactin-secreting pituitary adenomas: when should we operate?
Vale FL; Deukmedjian AR; Hann S; Shah V; Morrison AD
Br J Neurosurg; 2013 Feb; 27(1):56-62. PubMed ID: 22938595
[TBL] [Abstract][Full Text] [Related]
14. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
[TBL] [Abstract][Full Text] [Related]
15. Resistance to bromocriptine in prolactinomas.
Pellegrini I; Rasolonjanahary R; Gunz G; Bertrand P; Delivet S; Jedynak CP; Kordon C; Peillon F; Jaquet P; Enjalbert A
J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
[TBL] [Abstract][Full Text] [Related]
16. 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
Andereggen L; Frey J; Andres RH; El-Koussy M; Beck J; Seiler RW; Christ E
Endocrine; 2017 Jan; 55(1):223-230. PubMed ID: 27688009
[TBL] [Abstract][Full Text] [Related]
17. Transsphenoidal microsurgical results of female patients with prolactinomas.
Ikeda H; Watanabe K; Tominaga T; Yoshimoto T
Clin Neurol Neurosurg; 2013 Sep; 115(9):1621-5. PubMed ID: 23498159
[TBL] [Abstract][Full Text] [Related]
18. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
[TBL] [Abstract][Full Text] [Related]
19. Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases.
Akin S; Isikay I; Soylemezoglu F; Yucel T; Gurlek A; Berker M
Acta Neurochir (Wien); 2016 May; 158(5):933-42. PubMed ID: 26970763
[TBL] [Abstract][Full Text] [Related]
20. Treatment and long-term follow-up results of prolactin secreting pituitary adenomas.
Scamoni C; Balzarini C; Crivelli G; Dorizzi A
J Neurosurg Sci; 1991; 35(1):9-16. PubMed ID: 1890464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]